Answers are grounded in this paper and cite their sources.
Background: Pneumonia remains a leading cause of morbidity and mortality in children worldwide, particularly in developing countries, where irrational antibiotic use contributes to antimicrobial resistance and poorer clinical outcomes. Objective: This study aimed to evaluate the profile and rationality of antibiotic use in pediatric patients with hospital-acquired pneumonia at Ar-Rasyid Islamic Hospital, Palembang, during 2023-2024. Methods: A descriptive, observational, retrospective study was conducted on 100 medical records of pediatric patients aged 0-12 years who met the inclusion criteria; rationality was assessed using the Gyssens method. Results: The majority of patients are male (63%), with infants under 1 year of age comprising the largest age group (76%). The most frequently used antibiotic is injectable ceftazidime (49.40%). Gyssens' analysis reveals that only 35% of antibiotic prescriptions are classified as rational (Category 0), while 33% show inappropriate dosing (Category IIa), 10% are administered for too long (Category IIIa), and 22% for too short a duration (Category IIIb). Conclusion: These findings indicate that the rationality of antibiotic use in pediatric hospital-acquired pneumonia patients at this institution remains suboptimal, with dosing irregularities and inappropriate duration of therapy as the predominant issues. Implementation of an evidence-based Antimicrobial Stewardship Program is therefore essential to improve prescribing practices and reduce the risk of antimicrobial resistance in this vulnerable population.
No takes yet. Share an insight, caveat, or question.
Marseli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: